Inclusion Criteria:
  -  Patients aged 21 years or younger at the time of enrollment on this study of any gender, race or ethnicity.
       -  Subjects with suspected or confirmed diagnosis of recurrent or refractory cancer
       -  Subjects who are scheduled for or have recently had biopsy or tumor excised (solid tumors) or bone marrow aspirate (blood cancers)
       -  Subjects willing to have a blood draw or buccal swab done for the purposes of genetic testing
       -  Subjects or their parents or legal guardians willing to sign informed consent
       -  Subjects aged 7 to 17 willing to sign assent
Exclusion Criteria:
  -  Subjects who do not have malignant tissue available and accessible
  -  The amount of excised malignant tissue is not sufficient for the ex vivo drug testing and/or genetic profiling.
  -  Patients with newly diagnosed tumors and tumors that have high (>90%) cure rate with safe standard therapy.